-transparent.png){kind=logo}
Alprazolam, when added under double-blind conditions to a stable neuroleptic regimen in two patients with schizophrenia, resulted in clinically apparent improvement in positive and negative schizophrenic symptoms. Both patients showed significant worsening of symptoms following reduction or discontinuation of alprazolam.
Related Publications
O M Wolkowitz, and
D Pickar, and
A R Doran, and
A Breier, and
J Tarell, and
S M Paul
November 1986,
The American journal of psychiatry,
O M Wolkowitz, and
D Pickar, and
A R Doran, and
A Breier, and
J Tarell, and
S M Paul
March 1991,
Biological psychiatry,
O M Wolkowitz, and
D Pickar, and
A R Doran, and
A Breier, and
J Tarell, and
S M Paul
January 1994,
West African journal of medicine,
O M Wolkowitz, and
D Pickar, and
A R Doran, and
A Breier, and
J Tarell, and
S M Paul
October 1993,
Biological psychiatry,
O M Wolkowitz, and
D Pickar, and
A R Doran, and
A Breier, and
J Tarell, and
S M Paul
June 1990,
Biological psychiatry,
O M Wolkowitz, and
D Pickar, and
A R Doran, and
A Breier, and
J Tarell, and
S M Paul
March 1992,
Archives of general psychiatry,
O M Wolkowitz, and
D Pickar, and
A R Doran, and
A Breier, and
J Tarell, and
S M Paul
July 1992,
The Journal of clinical psychiatry,
O M Wolkowitz, and
D Pickar, and
A R Doran, and
A Breier, and
J Tarell, and
S M Paul
July 1995,
Biological psychiatry,
O M Wolkowitz, and
D Pickar, and
A R Doran, and
A Breier, and
J Tarell, and
S M Paul
January 1991,
Psychiatria polska,
O M Wolkowitz, and
D Pickar, and
A R Doran, and
A Breier, and
J Tarell, and
S M Paul
October 1987,
Journal of clinical psychopharmacology,
